| scholarly article | Q13442814 |
| P50 | author | Jeffrey P Krischer | Q88380300 |
| P2093 | author name string | S Shah | |
| W Winter | |||
| J Silverstein | |||
| W Riley | |||
| D Schatz | |||
| A Muir | |||
| G Horne | |||
| R Spillar | |||
| D Derovanesian | |||
| P2860 | cites work | Evaluation of survival data and two new rank order statistics arising in its consideration | Q34054360 |
| Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase | Q34566310 | ||
| Initial pathogenic events in IDDM. | Q38609560 | ||
| Can we really predict IDDM? | Q40871649 | ||
| Islet cell antibodies in normal French schoolchildren | Q41115842 | ||
| Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes | Q41199553 | ||
| Polyclonal nature of islet cell antibodies in insulin-dependent diabetes | Q41359459 | ||
| Are insulin autoantibodies markers for insulin-dependent diabetes mellitus? | Q41450786 | ||
| Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus | Q41465592 | ||
| First-degree relatives of patients with type I diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion | Q43744706 | ||
| Islet cell antibodies as predictive markers for IDDM in children with high background incidence of disease | Q45019640 | ||
| Insulin and islet cell autoantibodies as time-dependent covariates in the development of insulin-dependent diabetes: a prospective study in relatives. | Q51599095 | ||
| Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. | Q52573866 | ||
| Improved specificity of ICA assays in the Fourth International Immunology of Diabetes Serum Exchange Workshop | Q53392926 | ||
| Assessment of precision, concordance, specificity, and sensitivity of islet cell antibody measurement in 41 assays. | Q53402532 | ||
| Predictive value of islet cell and insulin autoantibodies for Type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children | Q61861661 | ||
| Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies | Q68070794 | ||
| 64,000 Mr autoantibodies as predictors of insulin-dependent diabetes | Q68088864 | ||
| Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study | Q68171222 | ||
| Prevalence of islet cell antibodies, insulin antibodies and hyperglycaemia in 2291 schoolchildren | Q68219414 | ||
| A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes | Q68564203 | ||
| The Third International Workshop on the Standardisation of Insulin Autoantibody Measurement | Q68708130 | ||
| Competitive insulin autoantibody assay. Prospective evaluation of subjects at high risk for development of type I diabetes mellitus | Q69422346 | ||
| Insulin-dependent diabetes mellitus and autoimmunity: islet-cell autoantibodies, insulin autoantibodies, and beta-cell failure | Q69905910 | ||
| Predicting insulin-dependent diabetes | Q69915636 | ||
| How, when, and why to predict IDDM | Q70226544 | ||
| The incidence of diabetes mellitus in Swedish children 0-14 years of age. A prospective study 1977-1980 | Q71450436 | ||
| Islet cell antibodies in the Japanese population and subjects with type 1 (insulin-dependent) diabetes | Q93647338 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | United States of America | Q30 |
| antibody | Q79460 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 2403-2407 | |
| P577 | publication date | 1994-06-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives | |
| P478 | volume | 93 |
| Q28299381 | A population based strategy to prevent insulin-dependent diabetes using nicotinamide |
| Q46804221 | Activation of CD4+ and CD8+ T-lymphocytes by insulin and GAD in patients with type 1 or 2 diabetes mellitus |
| Q37103766 | Analysis of pathogenesis of juvenile new-onset diabetes |
| Q41695578 | Antibody screening in a population of children |
| Q55259964 | Autoantibodies to Chemokines and Cytokines Participate in the Regulation of Cancer and Autoimmunity. |
| Q77841503 | Autoantibodies to GAD, IA-2 and insulin in ICA-positive first-degree relatives of children with type 1 diabetes: a comparison between parents and siblings |
| Q39071519 | Autoantibody-defined risk for Type 1 diabetes mellitus in a general population of schoolchildren: results of the Karlsburg Type 1 Diabetes Risk Study after 18 years |
| Q41605577 | Autoimmune diabetes. The role of autoantibody markers in the prediction and prevention of insulin-dependent diabetes mellitus. |
| Q28602447 | Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da study |
| Q34423279 | Celiac disease and autoimmune thyroid disease in children with type 1 diabetes mellitus: clinical and HLA-genotyping results |
| Q50760046 | Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility. |
| Q72690798 | Combined analysis of IDDM-related autoantibodies in healthy schoolchildren |
| Q55262290 | Comparison of two insulin assays for first-phase insulin release in type 1 diabetes prediction and prevention studies. |
| Q35179922 | Development of autoantibodies in the TrialNet Natural History Study |
| Q33215130 | Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies |
| Q37446924 | Diabetes mellitus in neonates and infants: genetic heterogeneity, clinical approach to diagnosis, and therapeutic options |
| Q44051179 | Diabetes mellitus-related autoantibodies in childhood autoimmune hepatitis |
| Q81657563 | Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes |
| Q42771857 | Enhancing the understanding of pre-type 1 diabetes in the general population |
| Q42059990 | Expression, characterization, processing and immunogenicity of an insulin-dependent diabetes mellitus autoantigen, IA-2, in Sf-9 cells |
| Q40775475 | Glutamic acid decarboxylase and islet cell antibodies in healthy Estonian children. |
| Q34419575 | Identification of autoantibody-negative autoimmune type 2 diabetic patients |
| Q44620314 | Islet Autoantibodies in Cord Blood from Patients who developed Type 1 Diabetes Mellitus at 15–30 Years of Age |
| Q57449485 | Islet autoantibodies in the prediction of diabetes in school children |
| Q37359669 | Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice |
| Q40202257 | Organ specific autoantibodies in preclinical and early clinical type 1 diabetes in Turkey |
| Q50157817 | Patient and family reflections on the use of subcutaneous insulin to prevent diabetes: a retrospective evaluation from a pilot prevention trial |
| Q37807453 | Permanent neonatal diabetes mellitus - the importance of diabetes differential diagnosis in neonates and infants |
| Q40893814 | Pharmacological approaches to the prevention of autoimmune diabetes |
| Q37809121 | Prediction and prevention of Type 1 diabetes mellitus |
| Q36773474 | Prediction and prevention of type 1 diabetes: progress, problems, and prospects |
| Q39015884 | Prediction of type 1 diabetes in Sardinian schoolchildren using islet cell autoantibodies: 10-year follow-up of the Sardinian schoolchildren type 1 diabetes prediction study |
| Q33873033 | Prediction of type 1 diabetes in the general population |
| Q43938791 | Prevalence and fate of type 1 diabetes-associated autoantibodies in cord blood samples from newborn infants of non-diabetic mothers |
| Q36249543 | Prognostic accuracy of immunologic and metabolic markers for type 1 diabetes in a high-risk population: receiver operating characteristic analysis |
| Q34351648 | Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes |
| Q57449474 | Screening for prediabetes in the general child population: maternal attitude to participation |
| Q37106551 | Single nucleotide transcription factor 7-like 2 (TCF7L2) gene polymorphisms in antiislet autoantibody-negative patients at onset of diabetes |
| Q34182950 | Strategies for preventing type I diabetes mellitus |
| Q37288640 | The diagnostic role of autoantibodies in the prediction of organ-specific autoimmune diseases |
| Q58666538 | The ethics of type 1 diabetes prediction and prevention research |
| Q38126109 | The kidney as a new target for antidiabetic drugs: SGLT2 inhibitors |
| Q36526611 | The pathogenesis and natural history of type 1 diabetes |
| Q47626653 | Validation of a rapid type 1 diabetes autoantibody screening assay for community-based screening of organ donors to identify subjects at increased risk for the disease. |
| Q41312501 | Virus-induced autoimmune disease |
| Q35976503 | Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies |
Search more.